Patents by Inventor Herbert Wiesinger

Herbert Wiesinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10954546
    Abstract: The present invention relates to methods and apparatus for detecting one or more pathogens in one or more biological samples. The biological sample may be a food sample, a sample of a body fluid, a cell suspension, water, or a combination thereof. The present invention relates also to methods of diagnosing or predicting a disease in an individual.
    Type: Grant
    Filed: September 24, 2014
    Date of Patent: March 23, 2021
    Assignee: AIT Austrian Institute of Technology GmbH
    Inventors: Klemens Wassermann, Johannes Peham, Herbert Wiesinger-Mayr, Christa Nöhammer
  • Publication number: 20160222431
    Abstract: The present invention relates to methods and apparatus for detecting one or more pathogens in one or more biological samples. The biological sample may be a food sample, a sample of a body fluid, a cell suspension, water, or a combination thereof. The present invention relates also to methods of diagnosing or predicting a disease in an individual.
    Type: Application
    Filed: September 24, 2014
    Publication date: August 4, 2016
    Applicant: AIT Austrian Institute of Technology GmbH
    Inventors: Klemens Wassermann, Johannes Peham, Herbert Wiesinger-Mayr, Christa Nöhammer
  • Publication number: 20090291854
    Abstract: Disclosed is a method for identification of microbial pathogens in a body fluid sample comprising the following steps: a) providing a body fluid sample; b) lysing the microbial pathogens and performing a nucleic acid amplification reaction on the microbial DNA encoding 16S or 18S rRNA wherein or whereafter the amplified nucleic acids are labelled; c) contacting the labelled amplified nucleic acids of step b) with a microarray comprising on defined areas on the microarray's surface immobilised probes for microbial DNA encoding 16S or 18S rRNA from microbial pathogens; d) detecting the binding of one or more species of the labelled amplified nucleic acids to a probe by detecting a labelled amplified nucleic acid being specifically bound to the microarray; and e) identifying a microbial pathogen in the body fluid sample by correlating the detected binding of the labelled amplified nucleic acids with the defined areas of the immobilised probes for microbial DNA encoding 16S or 18S rRNA from microbial pathogens.
    Type: Application
    Filed: July 5, 2007
    Publication date: November 26, 2009
    Applicant: AUSTRIAN RESEARCH CENTERS GMBH - ARC
    Inventors: Herbert Wiesinger-Mayr, Rudolf Pichler, Levente Bodrossy, Christa Nohammer
  • Publication number: 20080038350
    Abstract: The peroral medication for prevention of conception contains as one active ingredient crystalline 17?-cyanomethyl-17?-hydroxyestra-4,9-dien-3-one (dienogest) at a daily dosage equal to or less than 2.0 mg and as another active ingredient 17?-ethinyl estradiol at a daily dosage of less than 0.030 mg, together with one or more pharmaceutically acceptable carriers. The active ingredient dienogest is contained in the medication in crystalline form with an average particle size of preferably 25 to 70 ?m. The other active ingredient ethinyl estradiol is incorporated during granulation in micronized form or by spraying an ethanolic solution containing it.
    Type: Application
    Filed: June 13, 2007
    Publication date: February 14, 2008
    Inventors: Hagen Gerecke, Sabine Fricke, Ralf Ladwig, Herbert Wiesinger, Alexander Buske
  • Patent number: 7211680
    Abstract: Compounds of Formula I, wherein Y1, Y2, R1–R6, Q and Z are as defined herein, are vitamin D derivatives. These compounds are useful for, e.g., the treatment hyperprolifierative diseases of the skin, tumor diseases and precancerous stages, auto-immune diseases, rejection reactions in the case of autologous, allogenic or xenogenic transplants, AIDS, atopic skin conditions, secondary hyperparathyroidism, renal osteodystrophia, senile and postmenopausal osteoporosis, diabetes mellitus type II, degenerative diseases of the peripheral and central nervous system, hypercalcemias, granulomatous diseases, paraneoplastic hypercalcemias, hypercalcemias in hyperparathyroidism, hirsutism, ateriosclerosis, and/or inflammatory diseases.
    Type: Grant
    Filed: September 10, 2003
    Date of Patent: May 1, 2007
    Assignee: Schering Aktiengesellschaft
    Inventors: Andreas Steinmeyer, Gerald Kirsch, Guenter Neef, Katiea Schwarz, Ruth Thieroff-Ekerdt, Herbert Wiesinger, Martin Haberey, Marianne Fahnrich
  • Patent number: 7071344
    Abstract: The invention relates to novel vitamin D derivatives of general formula (I), a method for the production thereof, intermediate products of the method and the utilization of vitamin D derivatives for producing medicaments.
    Type: Grant
    Filed: September 29, 1998
    Date of Patent: July 4, 2006
    Assignee: Schering AG
    Inventors: Andreas Steinmeyer, Gunter Neef, Gerald Kirsch, Katica Schwarz, Herbert Wiesinger, Martin Haberey, Marianne Fahnrich, Gernot Langer
  • Publication number: 20050227951
    Abstract: The invention relates to new vitamin D derivatives of general formula (I), process for their production, intermediate products of the process as well as the use for production of pharmaceutical agents.
    Type: Application
    Filed: June 1, 2005
    Publication date: October 13, 2005
    Inventors: Andreas Steinmeyer, Gunter Neef, Gerald Kirsch, Katica Schwarz, Herbert Wiesinger, Martin Haberey, Marianne Fahnrich, Gernot Langer
  • Publication number: 20050080058
    Abstract: Compounds of Formula I, wherein Y1, Y2, R1-R6, Q and Z are as defined herein, are vitamin D derivatives. These compounds are useful for, e.g., the treatment hyperprolifierative diseases of the skin, tumor diseases and precancerous stages, auto-immune diseases, rejection reactions in the case of autologous, allogenic or xenogenic transplants, AIDS, atopic skin conditions, secondary hyperparathyroidism, renal osteodystrophia, senile and postmenopausal osteoporosis, diabetes mellitus type II, degenerative diseases of the peripheral and central nervous system, hypercalcemias, granulomatous diseases, paraneoplastic hypercalcemias, hypercalcemias in hyperparathyroidism, hirsutism, ateriosclerosis, and/or inflammatory diseases.
    Type: Application
    Filed: September 10, 2003
    Publication date: April 14, 2005
    Applicant: Schering Aktiengesellschaft Patents
    Inventors: Andreas Steinmeyer, Gerald Kirsch, Gunter Neef, Katica Schwarz, Ruth Thieroff-Ekerdt, Herbert Wiesinger, Martin Haberey, Marianne Fahnrich
  • Patent number: 6642218
    Abstract: The invention relates to vitamin D derivatives of formula (I), processes for the production thereof and uses thereof: wherein Y1, Y2, R1-R6, Q and Z are as defined herein.
    Type: Grant
    Filed: December 11, 1998
    Date of Patent: November 4, 2003
    Assignee: Schering Aktiengesellschaft
    Inventors: Andreas Steinmeyer, Gerald Kirsch, Günter Neef, Katica Schwarz, Ruth Thieroff-Ekerdt, Herbert Wiesinger, Martin Haberey, Marianne Fahnrich
  • Patent number: 6613920
    Abstract: The invention relates to vitamin D derivatives of formula (I), processes for the production thereof and uses thereof: wherein Y1, Y2, R1—R6, Q and Z are as defined herein.
    Type: Grant
    Filed: October 25, 2000
    Date of Patent: September 2, 2003
    Assignee: Schering Aktiengesellschaft
    Inventors: Andreas Steinmeyer, Gerald Kirsch, Günter Neef, Katica Schwarz, Ruth Thieroff-Ekerdt, Herbert Wiesinger, Martin Haberey, Marianne Fahnrich
  • Patent number: 6600058
    Abstract: The invention concerns new vitamin D derivatives of general formula (I) a process for their production, their use for production of medicaments, and intermediate products used in the process.
    Type: Grant
    Filed: October 25, 2000
    Date of Patent: July 29, 2003
    Assignee: Schering Aktiengellschaft
    Inventors: Andreas Steinmeyer, Gerald Kirsch, Günter Neef, Katica Schwarz, Ruth Thieroff-Ekerdt, Herbert Wiesinger, Martin Haberey, Marianne Fahnrich
  • Publication number: 20030087913
    Abstract: A solid pharmaceutical agent formulation that contains (2R)-1-((4-chloro-2-(ureido)phenoxy)methyl)carbonyl-2-methyl-4-(4-fluorobenzyl)piperazine or a salt thereof is described.
    Type: Application
    Filed: October 18, 2002
    Publication date: May 8, 2003
    Applicant: Schering AG
    Inventors: Heiko Kranz, Christoph Volkel, Ralph Lipp, Johannes Tack, Herbert Wiesinger
  • Patent number: 6531459
    Abstract: Described are new vitamin D derivatives such as of the formula (I) detailed in this disclosure. Also described are methods for preparing these derivatives, inter mediates used to prepare the derivatives and use of the derivatives as pharmaceutical agents.
    Type: Grant
    Filed: August 4, 2000
    Date of Patent: March 11, 2003
    Assignee: Schering Aktiengesellschaft
    Inventors: Andreas Steinmeyer, Günter Neef, Gerald Kirsch, Katica Schwarz, Herbert Wiesinger, Martin Haberey, Marianne Fähnrich, Gernot Langer
  • Publication number: 20030018194
    Abstract: The invention relates to new vitamin D derivatives of general formula (I), process for their production, intermediate products of the process as well as the use for production of pharmaceutical agents.
    Type: Application
    Filed: August 8, 2002
    Publication date: January 23, 2003
    Inventors: Andreas Steinmeyer, Gunter Neef, Gerald Kirsch, Kauca Schwarz, Herbert Wiesinger, Martin Haberey, Marianne Fahnrich, Gernot Langer
  • Publication number: 20020049344
    Abstract: The invention concerns new vitamin D derivatives of general formula (I) a process for their production, their use for production of medicaments, and intermediate products used in the process.
    Type: Application
    Filed: December 11, 1998
    Publication date: April 25, 2002
    Inventors: ANDREAS STEINMEYER, GERALD KIRSCH, GUNTER NEFF, KATICA SCHWARZ, RUTH THIEROFF-EKERDT, HERBERT WIESINGER, MARTIN HABEREY, MARIANNE FAHNRICH
  • Patent number: 6376480
    Abstract: A method of preparing a pharmaceutical composition, comprising combining a pharmaceutically compatible vehicle with a compound according to formula (I)
    Type: Grant
    Filed: December 18, 2000
    Date of Patent: April 23, 2002
    Assignee: Schering Aktiengesellschaft
    Inventors: Gerald Kirsch, Andreas Steinmeyer, Günter Neef, Katica Schwarz, Ruth Thieroff-Ekerdt, Herbert Wiesinger, Andreas Menrad, Martin Haberey
  • Patent number: 6372731
    Abstract: A vitamin D derivative and its uses with substituents at C-25 of general formula I
    Type: Grant
    Filed: March 31, 1998
    Date of Patent: April 16, 2002
    Assignee: Schering Aktiengesellschaft
    Inventors: Gerald Kirsch, Andreas Steinmeyer, Günter Neef, Katica Schwarz, Ruth Thieroff-Ekerdt, Herbert Wiesinger, Andreas Menrad, Martin Haberey
  • Patent number: 5700791
    Abstract: The invention relates to vitamin D derivatives, modified in 20-position, of general formula I ##STR1## in which X, Y, Z, R.sub.1, R.sub.2 as well as R.sub.3 have the meaning indicated in the description, process for their production and their use as agents for treatment of hyperproliferative diseases of the skin.
    Type: Grant
    Filed: June 14, 1996
    Date of Patent: December 23, 1997
    Assignee: Schering Aktiengesellschaft
    Inventors: Andreas Steinmeyer, Gunter Neef, Gerald Kirsch, Katica Schwarz, Ruth Thieroff-Ekerdt, Herbert Wiesinger, Martin Haberey
  • Patent number: 5663157
    Abstract: 22-En-24-a-oxa derivatives in the vitamin D series of general formula I ##STR1## in which R.sup.1, R.sup.2 and R.sup.4, independently of one another, each mean a hydrogen atom, an alkanoyl group with 1 to 9 carbon atoms or an aroyl group,R.sup.3 mean a hydrogen atom each or a linear or branched alkyl group each with 1 to 4 carbon atoms, a trifluoromethyl group each or a saturated or unsaturated carbocyclic or heterocyclic 3-, 4-, 5- or 6-membered ring formed together with the tertiary carbon atom, andX means an alkylene radical --(CH.sub.2).sub.n --with n=1, 2 or 3, process for their production and their pharmaceutical use for treating hyperproliferative diseases are disclosed.
    Type: Grant
    Filed: March 16, 1995
    Date of Patent: September 2, 1997
    Assignee: Schering Aktiengesellschaft
    Inventors: Andreas Steinmeyer, Gerald Kirsch, Gunter Neef, Katica Schwarz, Ruth Thieroff-Ekerdt, Herbert Wiesinger, Martin Haberey
  • Patent number: 5585368
    Abstract: The invention relates to vitamin D derivatives, modified in 20-position, of general formula I ##STR1## in which X, Y, Z, R.sub.1, R.sub.2 as well as R.sub.3 have the meaning indicated in the description, process for their production and their use as agents for treatment of hyperproliferative diseases of the skin.
    Type: Grant
    Filed: June 24, 1993
    Date of Patent: December 17, 1996
    Assignee: Schering Aktiengesellschaft
    Inventors: Andreas Steinmeyer, Gunter Neef, Gerald Kirsch, Katica Schwarz, Ruth Thieroff-Ekerdt, Herbert Wiesinger, Martin Haberey